Given that CLL B cells can produce IL10 and TGFβ1 and their functional impact on their immune cells, we examined the clinical relevance of the frequencies of IL10- and TGFβ1-expressing cells. This evidence concerns the gene IL10 and B-cell chronic lymphocytic leukemia.